<DOC>
	<DOCNO>NCT01457001</DOCNO>
	<brief_summary>Multicentric randomize Italian clinical trial , open label , profit . To evaluate efficacy 25-OH-D vitamin term myocardial infarction , stroke , sudden death , death cause chronic haemodialysis patient . Two arm treatment : 25-OH-D vitamin per o versus treatment .</brief_summary>
	<brief_title>Clinical Trial Use 25-OH -D Vitamin Haemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>age &gt; = 18 year hematic PTH level twofoldninefold upper limit hematic level 25OHD vitamin &lt; 30 ng/ml renal transplant peritoneal dialysis le 3 year ago pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic haemodialysis</keyword>
	<keyword>25-OH-D vitamin</keyword>
</DOC>